Life Style and Parkinson's Disease

Overview

Journal J Neural Transm (Vienna)

Specialties Neurology
Physiology

Date 2022 May 23

PMID 35606622

Authors

Heinz Reichmann

Ilona Csoti

Jiri Koschel

Stefan Lorenzl

Christoph Schrader

Juergen Winkler

Ullrich Wullner

Affiliations

Soon will be listed here.

Abstract

The question whether life style may impair the advent or course of the disease in patients with Parkinsonism is of great importance for patients and physicians alike. We present here comprehensive information on the influence of the environment, diet (especially caffeine, nicotine, alcohol, chocolate and dairy products), physical activity and sleep on risk and course of Parkinson's disease.

Citing Articles

Investigating Parkinson's disease risk across farming activities using data mining and large-scale administrative health data.

Petit P, Berger F, Bonneterre V, Vuillerme N NPJ Parkinsons Dis. 2025; 11(1):13.

PMID: 39779703 PMC: 11711245. DOI: 10.1038/s41531-024-00864-2.

Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction.

Tanaka M, Vecsei L J Neural Transm (Vienna). 2024; 131(12):1367-1387.

PMID: 39110245 PMC: 11608389. DOI: 10.1007/s00702-024-02812-z.

A bibliometric analysis of speech and language impairments in Parkinson's disease based on Web of Science.

Pan X, Liang B, Cao T Front Psychol. 2024; 15:1374924.

PMID: 38962221 PMC: 11220271. DOI: 10.3389/fpsyg.2024.1374924.

Association of physical activity pattern and risk of Parkinson's disease.

Lin F, Lin Y, Chen L, Huang T, Lin T, He J NPJ Digit Med. 2024; 7(1):137.

PMID: 38783073 PMC: 11116521. DOI: 10.1038/s41746-024-01135-3.

From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?.

Vilela C, Araujo B, Soares-Guedes C, Caridade-Silva R, Martins-Macedo J, Teixeira C Cells. 2024; 13(9.

PMID: 38727306 PMC: 11083070. DOI: 10.3390/cells13090770.

References

Sasco A, Paffenbarger Jr R, Gendre I, Wing A . The role of physical exercise in the occurrence of Parkinson's disease. Arch Neurol. 1992; 49(4):360-5. DOI: 10.1001/archneur.1992.00530280040020. View

Liu R, Guo X, Park Y, Wang J, Huang X, Hollenbeck A . Alcohol Consumption, Types of Alcohol, and Parkinson's Disease. PLoS One. 2013; 8(6):e66452. PMC: 3686735. DOI: 10.1371/journal.pone.0066452. View

Hernan M, Chen H, Schwarzschild M, Ascherio A . Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol. 2003; 54(2):170-5. DOI: 10.1002/ana.10611. View

Bournival J, Quessy P, Martinoli M . Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol. 2009; 29(8):1169-80. PMC: 11505805. DOI: 10.1007/s10571-009-9411-5. View

Quik M, Huang L, Parameswaran N, Bordia T, Campos C, Perez X . Multiple roles for nicotine in Parkinson's disease. Biochem Pharmacol. 2009; 78(7):677-85. PMC: 2815339. DOI: 10.1016/j.bcp.2009.05.003. View

Mappin-Kasirer B, Pan H, Lewington S, Kizza J, Gray R, Clarke R . Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors. Neurology. 2020; 94(20):e2132-e2138. PMC: 7526668. DOI: 10.1212/WNL.0000000000009437. View

Lee P, Ahmed I, Loriot M, Mulot C, Paul K, Bronstein J . Smoking and Parkinson disease: Evidence for gene-by-smoking interactions. Neurology. 2018; 90(7):e583-e592. PMC: 5818012. DOI: 10.1212/WNL.0000000000004953. View

Altman R, Lang A, Postuma R . Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study. Mov Disord. 2011; 26(13):2427-31. DOI: 10.1002/mds.23873. View

Wills A, Eberly S, Tennis M, Lang A, Messing S, Togasaki D . Caffeine consumption and risk of dyskinesia in CALM-PD. Mov Disord. 2013; 28(3):380-3. PMC: 3608707. DOI: 10.1002/mds.25319. View

10.

Chen H, OReilly E, McCullough M, Rodriguez C, Schwarzschild M, Calle E . Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol. 2007; 165(9):998-1006. PMC: 2232901. DOI: 10.1093/aje/kwk089. View

11.

Gallo V, Vineis P, Cancellieri M, Chiodini P, Barker R, Brayne C . Exploring causality of the association between smoking and Parkinson's disease. Int J Epidemiol. 2018; 48(3):912-925. PMC: 6659366. DOI: 10.1093/ije/dyy230. View

12.

Palacios N, Gao X, OReilly E, Schwarzschild M, McCullough M, Mayo T . Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women. Mov Disord. 2012; 27(8):980-7. PMC: 3548327. DOI: 10.1002/mds.25050. View

13.

Liu C, Liu Z, Zhang Z, Li Y, Fang R, Li F . A Scientometric Analysis and Visualization of Research on Parkinson's Disease Associated With Pesticide Exposure. Front Public Health. 2020; 8:91. PMC: 7154051. DOI: 10.3389/fpubh.2020.00091. View

14.

Onyinyechi Anyanwu B, Ezejiofor A, Igweze Z, Orisakwe O . Heavy Metal Mixture Exposure and Effects in Developing Nations: An Update. Toxics. 2018; 6(4). PMC: 6316100. DOI: 10.3390/toxics6040065. View

15.

Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, Tuomilehto J . Body mass index and the risk of Parkinson disease. Neurology. 2006; 67(11):1955-9. DOI: 10.1212/01.wnl.0000247052.18422.e5. View

16.

Taguchi T, Ikuno M, Hondo M, Parajuli L, Taguchi K, Ueda J . α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model. Brain. 2019; 143(1):249-265. DOI: 10.1093/brain/awz380. View

17.

Ahmed H, Abushouk A, Gabr M, Negida A, Abdel-Daim M . Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations. Biomed Pharmacother. 2017; 90:638-649. DOI: 10.1016/j.biopha.2017.03.100. View

18.

Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-Sherlock B . Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial. Ann Rheum Dis. 2012; 71(6):929-34. DOI: 10.1136/annrheumdis-2011-200156. View

19.

Park M, Ross G, Petrovitch H, White L, Masaki K, Nelson J . Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005; 64(6):1047-51. DOI: 10.1212/01.WNL.0000154532.98495.BF. View

20.

Logroscino G, Sesso H, Paffenbarger Jr R, Lee I . Physical activity and risk of Parkinson's disease: a prospective cohort study. J Neurol Neurosurg Psychiatry. 2006; 77(12):1318-22. PMC: 1647294. DOI: 10.1136/jnnp.2006.097170. View